Teradyne Q3 GAAP EPS guidance of $1.79-$2.09 beats $1.55 estimate
Teradyne's Q3 guidance beats estimates on all key fronts: GAAP EPS ($1.79-$2.09 vs $1.55), adjusted EPS ($1.85-$2.15 vs $1.53), and sales ($1.200B-$1.300B vs $1.042B), signaling strong demand.
*this image is generated using AI for illustrative purposes only.
Teradyne (NASDAQ: TER) has announced third-quarter guidance that significantly outperforms analyst expectations across both GAAP and adjusted metrics for earnings per share and sales revenue. The test and measurement technology provider forecasts GAAP EPS in the range of $1.79 to $2.09, beating the $1.55 analyst estimate. Concurrently, the company projects adjusted EPS between $1.85 and $2.15 against a $1.53 consensus, with sales guidance of $1.200 billion to $1.300 billion exceeding the $1.042 billion expectation. This broad-based positive variance signals strong operational momentum and robust demand within the semiconductor and industrial testing sectors.
The divergence between Teradyne’s internal projections and external analyst models highlights a potential underestimation of near-term market conditions by Wall Street. By setting a floor for GAAP EPS at $1.79, the company indicates confidence in its ability to maintain margin integrity despite broader market volatility. The sales guidance, with a lower bound of $1.200 billion, suggests that order inflows or product mix improvements have likely accelerated beyond prior assumptions.
Guidance vs. Estimates
The following table outlines the key financial metrics from Teradyne’s Q3 guidance compared to prevailing analyst estimates:
| Metric | Teradyne Guidance | Analyst Estimate |
|---|---|---|
| GAAP EPS | $1.79 - $2.09 | $1.55 |
| Adjusted EPS | $1.85 - $2.15 | $1.53 |
| Sales Revenue | $1.200B - $1.300B | $1.042B |
What the Numbers Show
The most material aspect of this update is the breadth of the beat across both top-line and bottom-line metrics, including GAAP profitability. Typically, when companies exceed estimates, it is driven by either volume growth (sales) or cost efficiencies (EPS). Here, Teradyne is signaling strength in both areas. The gap between the lower end of the GAAP EPS range ($1.79) and the estimate ($1.55) represents a substantial percentage uplift, implying that the company expects not just higher revenues but also effective leverage of those revenues into profit. This dual-beat scenario often leads to re-rating of equity valuations as investors adjust their models for higher sustainable profitability.
Will Teradyne's significant beat on both top-line revenue and bottom-line GAAP EPS trigger a broader re-rating of semiconductor equipment valuations?
How might this unexpected strength in industrial testing demand influence Teradyne's capital allocation strategy for the remainder of the fiscal year?
Could the divergence between Teradyne's guidance and Wall Street estimates signal a wider underestimation of near-term recovery in the semiconductor supply chain?
19
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
